Pre-Filled Syringes Market Report 2026-2036: 9.2% CAGR
18 May 2026.
The global Pre-Filled Syringes market is projected to grow at a CAGR of 9.2% by 2036
Healthcare & Pharma
mRNA Vaccines Market Report 2026-2036: 13.6% CAGR
14 May 2026.
The global mRNA Vaccines market is projected to grow at a CAGR of 13.6% by 2036
Pharma’s New Backbone: The Distribution Advantage
13 May 2026.
Pharma distribution becomes strategic as speciality medicines reshape access and infrastructure
IoMT in Healthcare: The Move to Continuous, Data-Driven Care
13 May 2026.
IoMT is reshaping healthcare through AI, wearables and connected care.
Beyond the Batch: Pharma Manufacturing Becomes Strategic
6 May 2026.
CDMOs become strategic partners as biologics complexity reshapes pharmaceutical manufacturing
Pharmaceutical Packaging Moves Up the Value Chain
29 April 2026.
Pharmaceutical packaging is becoming strategic, smarter, sustainable and growth-critical
Pharmaceutical Contract Manufacturing Market Report 2026-2036: 7.9% CAGR
27 April 2026.
The global Pharmaceutical Contract Manufacturing market is projected to grow at a CAGR of 7.9% by 2036
Pharmaceutical Packaging Market 2026-2036: 8.8% CAGR
23 April 2026.
The global Pharmaceutical Packaging market is projected to grow at a CAGR of 8.8% by 2036
mRNA Cancer Vaccine Market Report 2026-2036: 27.1% CAGR
21 April 2026.
The global mRNA Cancer Vaccine market is projected to grow at a CAGR of 27.1% by 2036
Cell & Gene Therapy Market Report 2026-2036: 17.3% CAGR
7 April 2026.
The global cell & gene therapy market is projected to grow at a CAGR of 17.3% by 2036
The Race to Own Alzheimer’s: New Therapies Reshape Market
1 April 2026.
Alzheimer’s shifts to early intervention, with innovation reshaping competitive dynamics.
Decentralised Clinical Trials: From Adoption to Execution Risk
25 March 2026.
Decentralised trials shift from adoption to execution as complexity rises
Global Decentralised Clinical Trials Market 2026-2036: CAGR 11.5%
23 March 2026.
The global decentralised clinical trials market is projected to grow at a CAGR of 11.5% by 2036
Rheumatoid Arthritis Is Entering a New Competitive Phase
18 March 2026.
RA market shifting beyond biologics, driven by access, innovation, and pricing
The GLP-1 Boom: A Drug Class Redefining the Obesity Market
13 March 2026.
GLP-1 therapies are transforming obesity treatment and reshaping the global pharmaceutical market
Precision Payloads: The Rise of Antibody Drug Conjugates in Modern Oncology
4 March 2026.
Antibody drug conjugates are reshaping oncology through precision targeting, expanding pipelines and industry partnerships
Durability and Delivery: How Biologics Are Redefining Ophthalmology
25 February 2026.
Ophthalmology shifts to durable growth through biologics, delivery innovation and consolidation.
Biologic Innovation to Drive Global Ophthalmic Drugs at 7.9% CAGR
17 February 2026.
Ophthalmics offers durable growth amid broader pharma market volatility
Fill-Finish Manufacturing Is Now a Strategic Constraint
11 February 2026.
Fill-finish capacity now defines biologics launches, valuation strength, and competitive leverage
Longevity Market to Grow at 8.6% CAGR as Institutional Adoption Accelerates
9 February 2026.
The global Longevity market is projected to grow at a CAGR of 8.6% by 2036
